top of page

AI-CAC improves on CAC for Cardiovascular Risk prediction: The Multi-Ethnic Study of Atherosclerosis



AUTHORS (FIRST NAME, LAST NAME):

Morteza Naghavi, Anthony Reeves, Matthew Budoff, Dong Li, Kyle Atlas, Chenyu Zhang, Thomas Atlas, Sion K. Roy, Nathan D. Wong, Claudia Henschke, and David Yankelevitz.


Abstract:


Background:

Traditionally derived coronary artery calcium (CAC) scoring offers valuable information beyond traditional risk factors that significantly improve early detection of patients at risk for cardiovascular events.  We examined whether artificial intelligence-enabled methods utilizing the CAC scan may provide further improvement in overall cardiovascular disease (CVD) risk prediction.


Methods:

We applied artificial intelligence-enabled automated cardiac chambers volumetry to CAC scans (AI-CAC) of 5830 asymptomatic individuals (52.2% women, age 61.7±10.2 years) that were previously obtained for CAC scoring in the baseline examination (2000-2002) of the Multi-Ethnic Study of Atherosclerosis (MESA). The primary outcome was a composite of all cardiovascular events comprised of stroke, myocardial infarction, angina, resuscitated cardiac arrest, all cardiovascular disease related deaths, heart failure, and atrial fibrillation. We used the 15-year outcomes data and assessed discrimination using the time-dependent area under the curve (AUC) and Uno’s C-statistic between AI-CAC with Agatston CAC Score.


Results:

Over 15-years follow-up, 1773 cardiovascular events accrued. AI-CAC automated cardiac chambers volumetry took on average 21 seconds per CAC scan. The C-statistic for cardiovascular events between AI-CAC and Agatston CAC Score was 0.746 (CI: 0.724-0.768) versus 0.707 (CI: 0.683-0.723) for females, respectively (p<.0001) and 0.680 (CI: 0.653-0.707) versus 0.657 (CI: 0.632-0.682) for males, respectively (P=0.0012).  The category-free Net Reclassification Index of AI-CAC over CAC at 15-years follow-up for cardiovascular events was 0.29 (p<.0001).

 

Conclusion:

In this multi-ethnic longitudinal population study followed for 15 years, the addition of AI-CAC measurements significantly improved on Agatston CAC score for all cardiovascular event prediction.






Comments


Contact Us Today

We'd love to hear from you. Please fill this form to request more information.

I'm interested in:
How did you hear about us?

Thank you for your interest.

A HeartLung representative will contact you as soon as possible!

  • Twitter
  • LinkedIn
  • Facebook
  • Instagram
  • Youtube

2450 Holcombe Blvd
TMC Innovations
Houston, TX 77021

©2025 HeartLung Corporation. All Rights Reserved. US Patent Nos US9119590*, US10695022, US11610686. and Patents Pending. AutoBMD™, AutoCAC™, AutoChamber™ and other trademarks shown on this website are protected under intellectual property rights of HeartLung Corporation in the United States.

bottom of page